--- title: "Winbase's controlling shareholder Zhuhai Shiyou plans to reduce its holdings by no more than 3%" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/252024899.md" description: "According to the Zhitong Finance APP, Winbase announced that the company's controlling shareholder Zhuhai Shiyou Chemical Co., Ltd. (referred to as \"Zhuhai Shiyou\") plans to reduce its holdings through centralized bidding and block trading, totaling no more than 12.1033 million shares (accounting for 3% of the total share capital after excluding shares in the company's repurchase special account)" datetime: "2025-08-07T11:36:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/252024899.md) - [en](https://longbridge.com/en/news/252024899.md) - [zh-HK](https://longbridge.com/zh-HK/news/252024899.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/252024899.md) | [English](https://longbridge.com/en/news/252024899.md) # Winbase's controlling shareholder Zhuhai Shiyou plans to reduce its holdings by no more than 3% According to the Zhitong Finance APP, Winbase (002492.SZ) announced that its controlling shareholder Zhuhai Shiyou Chemical Co., Ltd. (referred to as "Zhuhai Shiyou") plans to reduce its holdings through centralized bidding and block trading, totaling no more than 12.1033 million shares (accounting for 3% of the total share capital after excluding shares in the company's repurchase special account) ### 相關股票 - [Winbase (002492.CN)](https://longbridge.com/zh-HK/quote/002492.CN.md) ## 相關資訊與研究 - [Franco-Nevada (NYSE:FNV) Sees Large Volume Increase Following Strong Earnings](https://longbridge.com/zh-HK/news/278761206.md) - [Kansas City International Airport reopens after brief closure due to unspecified threat](https://longbridge.com/zh-HK/news/278278269.md) - [Xprize founder Peter Diamandis launches new contest to manifest a new Star Trek](https://longbridge.com/zh-HK/news/278419951.md) - [11:41 ETNovafjord Expands Multi-Asset Trading Services With AI-Driven Arbitrage and Risk Management Tools](https://longbridge.com/zh-HK/news/278417992.md) - [12:23 ETFull Circles Therapeutics Highlights Circular Single-Stranded DNA Platform Enabling Immune-Evasive Genome Writing in Nature Study](https://longbridge.com/zh-HK/news/278753990.md)